The earnings call highlighted several achievements including record revenue, strong growth in new product sales, robust margins, and a positive outlook for 2026. However, the call also noted some challenges such as organic revenue decline, issues in the Precision Medicine segment, and lower operating cash flows. The positive aspects, including strategic growth initiatives and market leadership, outweigh the negatives.

Company Guidance

During the third quarter 2025 earnings call for Novanta Inc., the company reported exceeding expectations with a revenue of $248 million, reflecting a 3% sequential increase and a 1% year-over-year growth, despite a 4% organic revenue decline. The adjusted gross margin was 46.5%, while the adjusted EBITDA margin was over 23%. Novanta highlighted a 17% increase in customer bookings year-over-year and a 50% year-to-date rise in design wins. The company expects to achieve mid-single-digit organic growth for 2026, driven by strong momentum in its growth platforms and new product launches. Novanta's strategic areas, including AI-driven robotics, advanced surgery, and precision medicine, are positioned to capitalize on long-term secular tailwinds, with medical markets accounting for 53% of year-to-date revenue. The company is also advancing its acquisition pipeline while maintaining a disciplined approach to leverage and cash returns.

Record Revenue and Growth Metrics

Novanta delivered record revenue of $248 million, surpassing guidance with a 1% reported revenue growth and a 60% year-over-year increase in new product revenue. Customer bookings grew 17% year-over-year and 4% sequentially.

Strong Performance in Medical Solutions

The Medical Solutions segment revenue was up 6% year-over-year with a book-to-bill ratio of 1.1. The Advanced Surgery business experienced 17% growth year-over-year.

Robust Margins and Financial Performance

Adjusted gross margins overdelivered at 46.5%, and adjusted EBITDA margins were above 23%. Adjusted earnings per share increased by 2% year-over-year and 14% sequentially.

Successful New Product Launches and Design Wins

Novanta launched 20 new products year-to-date, and design win activity was up 50% year-to-date. New product sales grew by over 40% year-over-year in the Medical Solutions segment.

Positive Outlook for 2026

Novanta expects mid-single-digit organic growth for the full year 2026, driven by strategic investments in AI-driven robotics, automation, and medical technologies.

Novanta (NOVT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

NOVT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 04, 2026	2025 (Q4)	0.91 / -	0.76	―	―	―
Nov 03, 2025	2025 (Q3)	0.82 / 0.87	0.85	2.35% (+0.02)	―
Aug 05, 2025	2025 (Q2)	0.73 / 0.76	0.73	4.11% (+0.03)	―
May 06, 2025	2025 (Q1)	0.67 / 0.74	0.74	0.00% (0.00)	―
Feb 25, 2025	2024 (Q4)	0.71 / 0.76	0.63	20.63% (+0.13)	―
Nov 05, 2024	2024 (Q3)	0.85 / 0.85	0.85	0.00% (0.00)	―
Aug 06, 2024	2024 (Q2)	0.69 / 0.73	0.8	-8.75% (-0.07)	―
May 07, 2024	2024 (Q1)	0.58 / 0.74	0.74	0.00% (0.00)	―
Feb 28, 2024	2023 (Q4)	0.63 / 0.63	0.75	-16.00% (-0.12)	―
Nov 07, 2023	2023 (Q3)	0.74 / 0.85	0.81	4.94% (+0.04)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

NOVT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 03, 2025	$135.86	$129.33	-4.81%
Aug 05, 2025	$124.01	$115.70	-6.70%
May 06, 2025	$120.01	$117.69	-1.93%
Feb 25, 2025	$138.30	$148.25	+7.19%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Novanta Inc (NOVT) report earnings?

Novanta Inc (NOVT) is schdueled to report earning on Mar 04, 2026, Before Open (Confirmed).

What is Novanta Inc (NOVT) earnings time?

Novanta Inc (NOVT) earnings time is at Mar 04, 2026, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is NOVT EPS forecast?

NOVT EPS forecast for the fiscal quarter 2025 (Q4) is 0.91.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing